Phase II trial of ofatumumab (OFA) in previously untreated follicular non-hodgkin lymphoma (NHL): CALGB 50901 (alliance)

Category Primary study
JournalBlood
Year 2015
This article has no abstract
Epistemonikos ID: 923846a93856df5e27100c2c24368b19dc49d591
First added on: Feb 07, 2025